LONDON, June 29, 2017 /PRNewswire/ -- Smith &
Nephew (NYSE:SNN; LSE:SN), the global medical technology business,
today announces the launch of its NAVIO handheld robotics-assisted
total knee arthroplasty (TKA) application. This expands the NAVIO
platform to total knees, which comprise 80% of all knee replacement
surgeries globally. The TKA application supports Smith &
Nephew's JOURNEY II, LEGION Primary and GENESIS II Total Knee
Systems.
The NAVIO Surgical System is a next generation handheld robotics
platform designed to aid surgeons with implant alignment, ligament
balancing and bone preparation – key factors that can drive patient
satisfaction. The small footprint of the NAVIO Surgical system
allows for easy set up and portability. The TKA application
provides a streamlined and efficient workflow along with cut guides
specifically designed for handheld robotics-assisted surgery.
Furthermore, the NAVIO robotics-assisted system does not require a
preoperative image, such as a CT scan. This allows patients to
receive the benefits of robotics-assistance without the extra
steps, costs, and radiation associated with additional preoperative
imaging.
"The NAVIO system offers game changing improvements in precision
and accuracy without sacrificing efficiency. It allows surgeons the
control to create a patient-specific plan in the OR and the
confidence to execute with robotic precision," says Dr Joseph Burkhardt from southwest Michigan. "For the Total Knee, it provides
surgeons the ability to do more than they have ever been able to do
with standard instruments, resulting in improved functional
outcomes for the patient."
"The NAVIO partial knee replacement application has been
commercially available since 2014, including UKA and PFJ options,
and has developed a strong surgeon following," said Glenn Warner, President, US Commercial. "The
full market release of the TKA application provides a
robotics-assisted solution for one of the largest markets in
orthopaedics. Smith & Nephew is committed to continued
expansion and growth of the NAVIO robotics-assisted platform."
About Smith & Nephew
Smith & Nephew is a global medical technology business
dedicated to helping healthcare professionals improve people's
lives. With leadership positions in Orthopaedic Reconstruction,
Advanced Wound Management, Sports Medicine and Trauma &
Extremities, Smith & Nephew has around 15,000 employees and a
presence in more than 100 countries. Annual sales in 2016 were
almost $4.7 billion. Smith &
Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
For more information about Smith & Nephew, please visit our
website www.smith-nephew.com, follow @SmithNephewplc on Twitter or
visit SmithNephewplc on Facebook.com.
Forward-looking Statements
This document may
contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth
and trading margins, market trends and our product pipeline are
forward-looking statements. Phrases such as "aim", "plan",
"intend", "anticipate", "well-placed", "believe", "estimate",
"expect", "target", "consider" and similar expressions are
generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith & Nephew, these factors include:
economic and financial conditions in the markets we serve,
especially those affecting health care providers, payers and
customers; price levels for established and innovative medical
devices; developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls or other problems with quality management
systems or failure to comply with related regulations; litigation
relating to patent or other claims; legal compliance risks and
related investigative, remedial or enforcement actions; disruption
to our supply chain or operations or those of our suppliers;
competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due
diligence, valuing and integrating acquired businesses; disruption
that may result from transactions or other changes we make in our
business plans or organisation to adapt to market developments; and
numerous other matters that affect us or our markets, including
those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission
under the U.S. Securities Exchange Act of 1934, as amended,
including Smith & Nephew's most recent annual report on Form
20-F, for a discussion of certain of these factors. Any
forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or
oral forward-looking statements attributable to Smith & Nephew
are qualified by this caution. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement to reflect any change in circumstances or in Smith &
Nephew's expectations.
™Trademark of Smith & Nephew. Certain marks
registered US Patent and Trademark Office.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/smith--nephew-expands-navio-robotics-assisted-surgery-system-into-total-knee-replacements-300481704.html
SOURCE Smith & Nephew